| # | Drug | Count |
|---|---|---|
| 0 | NEVIRAPINE | 51 |
| 1 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 50 |
| 2 | TENOFOVIR DISOPROXIL FUMARATE | 31 |
| 3 | ZIDOVUDINE | 31 |
| 4 | ADALIMUMAB | 26 |
| 5 | LAMIVUDINE | 25 |
| 6 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 24 |
| 7 | ANTIHEMOPHILIC FACTOR HUMAN | 21 |
| 8 | LAMIVUDINE ORAL | 21 |
| 9 | FACTOR IX COMPLEX | 20 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FACTOR IX COMPLEX | 20 | 0.0171 |
| 1 | ANTIHEMOPHILIC FACTOR HUMAN | 21 | 0.0155 |
| 2 | NEVIRAPINE | 51 | 0.0057 |
| 3 | HYDROCHLORIC ACID | 1 | 0.0045 |
| 4 | LENACAPAVIR SODIUM | 2 | 0.0040 |
| 5 | ZIDOVUDINE | 31 | 0.0030 |
| 6 | THROMBIN HUMAN AND FIBRINOGEN | 1 | 0.0030 |
| 7 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 24 | 0.0028 |
| 8 | NELFINAVIR MESYLATE | 4 | 0.0019 |
| 9 | EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 19 | 0.0017 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 53 | 0.0022 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 151 | 0.0014 |
| 3 | CCR5 Co-receptor Antagonist [EPC] | 3 | 0.0013 |
| 4 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 5 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 2 | 0.0011 |
| 6 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 34 | 0.0007 |
| 7 | Cytochrome P450 3A Inhibitor [EPC] | 33 | 0.0005 |
| 8 | Protease Inhibitor [EPC] | 23 | 0.0005 |
| 9 | Interleukin-17A Antagonist [EPC] | 14 | 0.0004 |